Clinical Research and Development, the delivery pathway to boost expansion

Delivery pathway

Life Sciences, the pharmaceutical sector in particular, has been experiencing exponential growth all over the world in the post-pandemic era. A record 283 new life sciences companies were formed in the first quarter of 2023 in the UK. That puts a lot of pressure on the market from the supply chain perspective, through time constraints of the regulator (MHRA) to availability of adequate laboratory space. To support that imminent growth of the sector and to align regional aspirations with government strategy, a record number of investment is going into the real estate sector, exceeding a whooping £496m in Q1 of 2023 alone.

Charnwood Campus Science Innovation and Technology Park is no exception. The park has been growing rapidly and welcomed a new large tenant just recently, Charnwood Molecular a medicinal chemistry and process research organisation – a great success story of a local university spin-out securing venture capital and moving into one of the largest buildings on site (110,000sqft), and shortly after, acquired a biology services company, Aurelia Bioscience, to further support their business growth.

The site is home to a number of blue-chip organisations and several high growth SME’s: including Almac Group’s drug development services, 3M Health Care’s national centre, Kindeva Drug Delivery System’s manufacturing and R&D. The Campus also delivered the fully refurbished premises for the Charnwood Lighthouse Laboratory for DHSC during Covid19 pandemic.

*Please contact for more information about laboratory space available

Looking to the Future

Ms. Gosia Khrais, the company’s Marketing and Commercial Director says “It is an exciting time for life sciences sector in the UK. Charnwood Campus has proven it plays a leading role in driving the life sciences sector agenda forward and is indeed starting to create meaningful and agile Life Sciences Cluster in Leicestershire. I would encourage companies looking to scale to reach out and secure a tour round the site as early as possible to avoid bottleneck situations in their business operations later. We are keen to support various phased out approaches to growth to facilitate expansion”. Dr Lucy Alexander Charnwood’s Business Development Lead/Manager added “The Campus is growing from a property proposition to a site that offers a variety of business support packages that support the ambitions of businesses within the biopharmaceutical, pharmaceutical, medtech or biotech sector. That is an additional benefit of moving into this fantastic life sciences park’’.

For more information please contact: for more information about laboratory space available


Posted in